165 related articles for article (PubMed ID: 28532224)
1. Comparing Clinical Outcomes of a Pharmacist-Managed Diabetes Clinic to Usual Physician-Based Care.
Schultz JL; Horner KE; McDanel DL; Miller ML; Beranek RL; Jacobsen RB; Sly NJ; Miller AC; Mascardo LA
J Pharm Pract; 2018 Jun; 31(3):268-271. PubMed ID: 28532224
[TBL] [Abstract][Full Text] [Related]
2. Improved Glycemic Control With Minimal Change in Medication Regimen Complexity in a Pharmacist-Endocrinologist Diabetes Intense Medical Management (DIMM) "Tune Up" Clinic.
Morello CM; Rotunno T; Khoan J; Hirsch JD
Ann Pharmacother; 2018 Nov; 52(11):1091-1097. PubMed ID: 29775079
[TBL] [Abstract][Full Text] [Related]
3. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
Altavela JL; Jones MK; Ritter M
J Manag Care Pharm; 2008; 14(9):831-43. PubMed ID: 19006440
[TBL] [Abstract][Full Text] [Related]
4. Pharmacist recommendations to improve the quality of diabetes care: a randomized controlled trial.
Kirwin JL; Cunningham RJ; Sequist TD
J Manag Care Pharm; 2010 Mar; 16(2):104-13. PubMed ID: 20178395
[TBL] [Abstract][Full Text] [Related]
5. A retrospective cohort analysis of the clinical effectiveness of a physician-pharmacist collaborative drug therapy management diabetes clinic.
Irons BK; Lenz RJ; Anderson SL; Wharton BL; Habeger B; Anderson HG
Pharmacotherapy; 2002 Oct; 22(10):1294-300. PubMed ID: 12389879
[TBL] [Abstract][Full Text] [Related]
6. Impact of clinical pharmacist intervention in anticoagulation clinic in Sudan.
Ahmed NO; Osman B; Abdelhai YM; El-Hadiyah TMH
Int J Clin Pharm; 2017 Aug; 39(4):769-773. PubMed ID: 28508324
[TBL] [Abstract][Full Text] [Related]
7. Pharmacist consultations in general practice clinics: the Pharmacists in Practice Study (PIPS).
Tan EC; Stewart K; Elliott RA; George J
Res Social Adm Pharm; 2014; 10(4):623-32. PubMed ID: 24095088
[TBL] [Abstract][Full Text] [Related]
8. Assessment of clinical pharmacist management of lipid-lowering therapy in a primary care setting.
Till LT; Voris JC; Horst JB
J Manag Care Pharm; 2003; 9(3):269-73. PubMed ID: 14613471
[TBL] [Abstract][Full Text] [Related]
9. Impact of pharmacist-managed erythropoiesis-stimulating agents clinics for patients with non-dialysis-dependent CKD.
Aspinall SL; Cunningham FE; Zhao X; Boresi JS; Tonnu-Mihara IQ; Smith KJ; Stone RA; Good CB;
Am J Kidney Dis; 2012 Sep; 60(3):371-9. PubMed ID: 22633556
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a pharmacist-managed amiodarone monitoring program.
Spence MM; Polzin JK; Weisberger CL; Martin JP; Rho JP; Willick GH
J Manag Care Pharm; 2011 Sep; 17(7):513-22. PubMed ID: 21870892
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacist intervention and the proportion of diabetes patients attaining prevention objectives in a multispecialty medical group.
Padiyara RS; D'Souza JJ; Rihani RS
J Manag Care Pharm; 2011; 17(6):456-62. PubMed ID: 21787031
[TBL] [Abstract][Full Text] [Related]
12. Assessing the Effect of Pharmacist Care on Diabetes-Related Outcomes in a Rural Outpatient Clinic: A Retrospective Case-Control Study.
Moreau C; Sando KR; Zambrano DH
Ann Pharmacother; 2017 Jun; 51(6):473-478. PubMed ID: 28064508
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of pharmacist-provided medication review in collaborative care for adult Singaporeans receiving hemodialysis.
Chia BY; Cheen MHH; Gwee XY; Chow MMY; Khee GY; Ong WC; Choong HL; Lim PS
Int J Clin Pharm; 2017 Oct; 39(5):1031-1038. PubMed ID: 28828593
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two different models of anticoagulation management services with usual medical care.
Rudd KM; Dier JG
Pharmacotherapy; 2010 Apr; 30(4):330-8. PubMed ID: 20334453
[TBL] [Abstract][Full Text] [Related]
15. Long-term Clinical and Cost Outcomes of a Pharmacist-managed Risk Factor Management Clinic in Singapore: An Observational Study.
Tan SH; Kng KK; Lim SM; Chan A; Loh JKK; Lee JY
Clin Ther; 2017 Dec; 39(12):2355-2365. PubMed ID: 29100730
[TBL] [Abstract][Full Text] [Related]
16. Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care.
Hall D; Buchanan J; Helms B; Eberts M; Mark S; Manolis C; Peele P; Docimo A
Pharmacotherapy; 2011 Jul; 31(7):686-94. PubMed ID: 21923456
[TBL] [Abstract][Full Text] [Related]
17. The Effectiveness of Pharmacist Interventions on Cardiovascular Risk in Adult Patients with Type 2 Diabetes: The Multicentre Randomized Controlled R
Al Hamarneh YN; Hemmelgarn BR; Hassan I; Jones CA; Tsuyuki RT
Can J Diabetes; 2017 Dec; 41(6):580-586. PubMed ID: 28965748
[TBL] [Abstract][Full Text] [Related]
18. A Markov model of the cost-effectiveness of pharmacist care for diabetes in prevention of cardiovascular diseases: evidence from Kaiser Permanente Northern California.
Yu J; Shah BM; Ip EJ; Chan J
J Manag Care Pharm; 2013 Mar; 19(2):102-14. PubMed ID: 23461426
[TBL] [Abstract][Full Text] [Related]
19. A comparison of clinical pharmacist management of type 2 diabetes versus usual care in a federally qualified health center.
Fink RM; Mooney EV; Saseen JJ; Billups SJ
Pharm Pract (Granada); 2019; 17(4):1618. PubMed ID: 31897259
[TBL] [Abstract][Full Text] [Related]
20. Impact of pharmacist-involved collaborative care on the clinical, humanistic and cost outcomes of high-risk patients with type 2 diabetes (IMPACT): a randomized controlled trial.
Siaw MYL; Ko Y; Malone DC; Tsou KYK; Lew YJ; Foo D; Tan E; Chan SC; Chia A; Sinaram SS; Goh KC; Lee JY
J Clin Pharm Ther; 2017 Aug; 42(4):475-482. PubMed ID: 28449205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
